Phase I study of low-dose suramin as a chemosensitizer in patients with advanced non-small cell lung cancer.
Villalona-Calero MA, Wientjes MG, Otterson GA, Kanter S, Young D, Murgo AJ, Fischer B, DeHoff C, Chen D, Yeh TK, Song S, Grever M, Au JL.
Villalona-Calero MA, et al. Among authors: otterson ga.
Clin Cancer Res. 2003 Aug 15;9(9):3303-11.
Clin Cancer Res. 2003.
PMID: 12960116
Clinical Trial.